Ligand ID: 20J Drugbank ID: DB01119(Diazoxide) Indication:Used parentally to treat hypertensive emergencies. Also used to treat hypoglycemia secondary to insulinoma. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.55A | 14.78 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | TYR A 209ARG A 217ILE A 281ALA A 211 | 1.26A | 14.78 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.55A | 14.78 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | TYR A 209ARG A 217ILE A 281ALA A 211 | 1.24A | 14.78 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.55A | 21.05 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.54A | 21.05 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6lzg | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR B 451VAL B 510ARG B 403ILE B 418 | 1.23A | 20.51 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6m03 | MAIN PROTEASE (SARS-CoV-2) | 4 / 7 | TYR A 209ARG A 217ILE A 281ALA A 211 | 1.08A | 21.05 | None | ||
![]() | 4LV9_B_20JB601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6m0j | SPIKE RECEPTORBINDING DOMAIN (SARS-CoV-2) | 4 / 7 | TYR E 451PHE E 347SER E 438ARG E 509 | 1.53A | 20.51 | None | ||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6m0j | SPIKE RECEPTORBINDING DOMAIN (SARS-CoV-2) | 4 / 8 | PHE E 347SER E 438ARG E 509TYR E 451 | 1.56A | 20.51 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.55A | 21.05 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.55A | 21.05 | None | ||
![]() | 4LV9_B_20JB601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6m17 | RECEPTOR BINDINGDOMAIN (SARS-CoV-2) | 4 / 7 | TYR E 451PHE E 497ASP E 442SER E 438 | 1.56A | 19.96 | None | ||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6m17 | RECEPTOR BINDINGDOMAIN (SARS-CoV-2) | 4 / 8 | PHE F 497ASP F 442SER F 438TYR F 451 | 1.56A | 19.96 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 7 | TYR B 209VAL B 204ILE B 281ALA B 211 | 1.58A | 21.05 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 7 | TYR D 209VAL D 204ILE D 281ALA D 211 | 1.44A | 21.05 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 7 | TYR C 209VAL C 204ILE C 281ALA C 211 | 1.55A | 21.05 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 7 | TYR C 209VAL C 204ILE C 281ALA C 211 | 1.55A | 21.05 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.57A | 21.05 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 7 | TYR D 209VAL D 204ILE D 281ALA D 211 | 1.45A | 21.05 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.54A | 21.05 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.54A | 21.05 | None | ||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6m3m | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 8 | ARG A 108SER C 52ALA C 56ARG C 108 | 1.60A | 14.16 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 4 / 7 | VAL C 53ILE D 106ILE D 107ALA D 110 | 1.68A | 12.30 | None | ||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | ARG A 553ASP A 452ALA A 558SER A 681 | 1.77A | 20.75 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 237VAL A 182ILE A 244ARG A 132 | 1.46A | 20.75 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 237VAL A 182ILE A 244ARG A 132 | 1.44A | 20.75 | None | ||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | PHE A 347SER A 438ARG A 509TYR A 451 | 1.64A | 19.19 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | VAL A1065ILE A 720ILE A 923ALA A 924 | 1.23A | 19.19 | None | ||
![]() | 4LV9_B_20JB601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR A 451PHE A 347SER A 438ARG A 509 | 1.61A | 19.19 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 7 | TYR A 152VAL A 30ILE A 23ALA A 124 | 1.53A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 7 | TYR B 152VAL B 30ILE B 23ALA B 124 | 1.45A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 7 | TYR B 152VAL B 30ILE B 23ALA B 124 | 1.46A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 7 | TYR A 152VAL A 30ILE A 23ALA A 124 | 1.51A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | VAL A 597ILE A 312ILE A 664ALA A 672 | 1.25A | 19.05 | None | ||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | PHE A 194ALA A 93SER A 94TYR A 91 | 1.67A | 19.05 | None | ||
![]() | 4LV9_B_20JB601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR A 91PHE A 194ALA A 93SER A 94 | 1.65A | 19.05 | None | ||
![]() | 4LV9_B_20JB601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | PHE C 823ASP C 820SER C 813ALA C 871 | 1.56A | 19.05 | None | ||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | PHE C 823ASP C 820SER C 813ALA C 871 | 1.53A | 19.05 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | VAL C 597ILE C 312ILE C 664ALA C 672 | 1.24A | 19.05 | None | ||
![]() | 4LV9_B_20JB601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 4 / 7 | TYR C 453PHE C 497SER C 349ARG C 403 | 1.29A | 15.89 | None | ||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 4 / 8 | PHE C 347ARG C 346ASP C 442SER C 438 | 1.62A | 15.89 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 4 / 7 | TYR C 508VAL C 510ARG C 408ILE C 418 | 1.35A | 15.89 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 4 / 7 | TYR C 508VAL C 510ILE C 410ILE C 418 | 1.34A | 15.89 | None | ||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 4 / 8 | PHE C 497SER C 349ARG C 403TYR C 453 | 1.30A | 15.89 | None | ||
![]() | 4LV9_B_20JB601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 4 / 7 | TYR C 451PHE C 497ASP C 442SER C 438 | 1.76A | 15.89 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 4 / 7 | TYR C 508VAL C 510ILE C 410ILE C 418 | 1.34A | 15.89 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 4 / 7 | TYR C 508VAL C 510ARG C 408ILE C 418 | 1.34A | 15.89 | None | ||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 4 / 8 | PHE C 497ASP C 442SER C 438TYR C 451 | 1.76A | 15.89 | None | ||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w4b | NSP9 (SARS-CoV-2) | 4 / 8 | ASP A 27SER A 14ALA A 29SER A 47 | 1.56A | 13.19 | None | ||
![]() | 4LV9_B_20JB601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w4b | NSP9 (SARS-CoV-2) | 4 / 7 | ASP A 27SER A 14ALA A 29SER A 47 | 1.53A | 13.19 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 7 | TYR A6845ILE A6925ILE A6967ALA A6966 | 1.78A | 15.88 | SAM A7104 (-4.6A)NoneNoneNone | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 4 / 7 | TYR A6845VAL B4295ILE A6838ALA A6843 | 1.44A | SAM A7104 (-4.6A)NoneNoneNone | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 4 / 7 | TYR A6845VAL B4295ILE A6838ALA A6843 | 1.44A | SAM A7104 (-4.6A)NoneNoneNone | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 7 | TYR A6845ILE A6925ILE A6967ALA A6966 | 1.76A | 15.88 | SAM A7104 (-4.6A)NoneNoneNone | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.52A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.52A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | TYR A 209ARG A 217ILE A 281ALA A 211 | 1.15A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | TYR B 152VAL B 30ILE B 23ALA B 124 | 1.46A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | TYR B 152VAL B 30ILE B 23ALA B 124 | 1.47A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | HIS A 94VAL A 35ILE A 23ALA A 50 | 1.77A | 18.22 | NoneNoneAMP A 201 ( 4.0A)None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | HIS A 94VAL A 35ILE A 23ALA A 50 | 1.77A | 18.22 | NoneNoneAMP A 201 ( 4.0A)None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | HIS B 94VAL B 35ILE B 23ALA B 50 | 1.76A | 18.22 | NoneNoneNoneMES B 201 ( 3.7A) | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | TYR A 152VAL A 30ILE A 23ALA A 124 | 1.47A | NoneNoneAMP A 201 ( 4.0A)None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | TYR A 152VAL A 30ILE A 23ALA A 124 | 1.46A | NoneNoneAMP A 201 ( 4.0A)None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | HIS B 94VAL B 35ILE B 23ALA B 50 | 1.77A | 18.22 | NoneNoneNoneMES B 201 ( 3.7A) | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 4 / 7 | TYR C6845VAL D4295ILE C6838ALA C6843 | 1.42A | 15.83 | SAM C7105 ( 4.5A)NoneNoneNone | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 4 / 7 | TYR C6845VAL D4295ILE C6838ALA C6843 | 1.43A | 15.83 | SAM C7105 ( 4.5A)NoneNoneNone | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 7 | TYR C6861ARG C7077ILE C7079ALA C6858 | 1.53A | 15.83 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 4 / 7 | TYR A6845VAL B4295ILE A6838ALA A6843 | 1.45A | 15.83 | SAM A7102 ( 4.5A)NoneNoneNone | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 7 | TYR C6845ILE C6925ILE C6967ALA C6966 | 1.71A | 15.83 | SAM C7105 ( 4.5A)NoneNoneNone | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 7 | TYR C6861ARG C7077ILE C7079ALA C6858 | 1.54A | 15.83 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 7 | TYR A6845ILE A6925ILE A6967ALA A6966 | 1.69A | 15.83 | SAM A7102 ( 4.5A)NoneNoneNone | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 7 | TYR C6845ILE C6925ILE C6967ALA C6966 | 1.68A | 15.83 | SAM C7105 ( 4.5A)NoneNoneNone | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 4 / 7 | TYR A6845VAL B4295ILE A6838ALA A6843 | 1.45A | 15.83 | SAM A7102 ( 4.5A)NoneNoneNone | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 7 | TYR A6845ILE A6925ILE A6967ALA A6966 | 1.72A | 15.83 | SAM A7102 ( 4.5A)NoneNoneNone | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 7 | TYR C 273HIS C 272ILE C 285ALA C 114 | 1.58A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 7 | TYR C 273HIS C 272ILE C 285ALA C 114 | 1.60A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 7 | TYR A 273HIS A 272ILE A 285ALA A 114 | 1.54A | None | |||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 8 | PHE B 304ASP B 302SER B 262ALA B 116 | 1.72A | 21.43 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 7 | TYR B 273HIS B 272ILE B 285ALA B 114 | 1.53A | NoneNone CL B 502 (-4.9A) CL B 502 ( 3.8A) | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 7 | TYR B 273HIS B 272ILE B 285ALA B 114 | 1.51A | NoneNone CL B 502 (-4.9A) CL B 502 ( 3.8A) | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 7 | TYR A 273HIS A 272ILE A 285ALA A 114 | 1.53A | None | |||
![]() | 4LV9_B_20JB601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w9q | 3C-LIKE PROTEINASEPEPTIDE, NSP9 FUSION (SARS-CoV-2) | 4 / 7 | ASP A 26SER A 13ALA A 28SER A 46 | 1.58A | 14.29 | None | ||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6w9q | 3C-LIKE PROTEINASEPEPTIDE, NSP9 FUSION (SARS-CoV-2) | 4 / 8 | ASP A 26SER A 13ALA A 28SER A 46 | 1.62A | 14.29 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 7 | TYR A 152VAL A 30ILE A 23ALA A 124 | 1.50A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 7 | TYR A 152VAL A 30ILE A 23ALA A 124 | 1.51A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wen | NSP3 (SARS-CoV-2) | 4 / 7 | TYR A 152VAL A 30ILE A 23ALA A 124 | 1.42A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wen | NSP3 (SARS-CoV-2) | 4 / 7 | TYR A 152VAL A 30ILE A 23ALA A 124 | 1.43A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wey | NSP3 (SARS-CoV-2) | 4 / 7 | TYR A 356VAL A 234ILE A 227ALA A 328 | 1.44A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wey | NSP3 (SARS-CoV-2) | 4 / 7 | TYR A 356VAL A 234ILE A 227ALA A 328 | 1.43A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wiq | NSP8 (SARS-CoV-2) | 4 / 7 | VAL B 130ILE B 120ILE B 106ALA B 150 | 1.45A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wiq | NSP8 (SARS-CoV-2) | 4 / 7 | VAL B 130ILE B 120ILE B 106ALA B 150 | 1.42A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 4 / 7 | TYR C6845VAL D4295ILE C6838ALA C6843 | 1.43A | SAH C7102 (-4.6A)NoneNoneNone | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 4 / 7 | TYR A6845VAL B4295ILE A6838ALA A6843 | 1.43A | SAH A7102 (-4.6A)NoneNoneNone | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 7 | TYR A6845ILE A6925ILE A6967ALA A6966 | 1.71A | SAH A7102 (-4.6A)NoneNoneNone | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 7 | TYR C6845ILE C6925ILE C6967ALA C6966 | 1.69A | SAH C7102 (-4.6A)NoneNoneNone | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 7 | TYR C6861ARG C7077ILE C7079ALA C6858 | 1.55A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 7 | TYR C6861ARG C7077ILE C7079ALA C6858 | 1.54A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 7 | TYR A6845ILE A6925ILE A6967ALA A6966 | 1.68A | SAH A7102 (-4.6A)NoneNoneNone | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 4 / 7 | TYR A6845VAL B4295ILE A6838ALA A6843 | 1.43A | SAH A7102 (-4.6A)NoneNoneNone | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 4 / 7 | TYR C6845VAL D4295ILE C6838ALA C6843 | 1.42A | SAH C7102 (-4.6A)NoneNoneNone | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 7 | TYR C6845ILE C6925ILE C6967ALA C6966 | 1.67A | SAH C7102 (-4.6A)NoneNoneNone | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 7 | TYR A 109ILE B 157ARG B 149ALA A 156 | 1.69A | MES B 201 (-4.3A)NoneNoneNone | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 7 | TYR A 109ILE B 157ARG B 149ALA A 156 | 1.69A | MES B 201 (-4.3A)NoneNoneNone | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 7 | TYR C6845ILE C6925ILE C6967ALA C6966 | 1.69A | SFG C7103 ( 4.5A)NoneNoneNone | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 4 / 7 | TYR C6845VAL D4295ILE C6838ALA C6843 | 1.42A | SFG C7103 ( 4.5A)NoneNoneNone | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 7 | TYR C6861ARG C7077ILE C7079ALA C6858 | 1.53A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 4 / 7 | TYR A6845VAL B4295ILE A6838ALA A6843 | 1.43A | SFG A7103 ( 4.6A)NoneNoneNone | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 7 | TYR A6845ILE A6925ILE A6967ALA A6966 | 1.71A | SFG A7103 ( 4.6A)NoneNoneNone | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 7 | TYR A6845ILE A6925ILE A6967ALA A6966 | 1.69A | SFG A7103 ( 4.6A)NoneNoneNone | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 4 / 7 | TYR C6845VAL D4295ILE C6838ALA C6843 | 1.42A | SFG C7103 ( 4.5A)NoneNoneNone | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 4 / 7 | TYR A6845VAL B4295ILE A6838ALA A6843 | 1.43A | SFG A7103 ( 4.6A)NoneNoneNone | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 7 | TYR C6845ILE C6925ILE C6967ALA C6966 | 1.71A | SFG C7103 ( 4.5A)NoneNoneNone | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 7 | TYR C6861ARG C7077ILE C7079ALA C6858 | 1.54A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 7 | TYR B 231VAL B 304ILE B 236ALA B 232 | 1.59A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 7 | TYR A 231VAL A 304ILE A 236ALA A 232 | 1.60A | SO4 A 410 (-3.3A)NoneNoneNone | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 7 | TYR A 231VAL A 304ILE A 236ALA A 232 | 1.58A | SO4 A 410 (-3.3A)NoneNoneNone | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 7 | TYR B 231VAL B 304ILE B 236ALA B 232 | 1.58A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.51A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.51A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | TYR B 152VAL B 30ILE B 23ALA B 124 | 1.49A | NoneNoneAPR B 201 (-3.8A)None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | TYR C 152VAL C 30ILE C 23ALA C 124 | 1.46A | NoneNoneAPR C 201 (-3.9A)None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | TYR B 152VAL B 30ILE B 23ALA B 124 | 1.50A | NoneNoneAPR B 201 (-3.8A)None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | TYR A 152VAL A 30ILE A 23ALA A 124 | 1.49A | NoneNoneAPR A 201 (-4.0A)None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | TYR C 152VAL C 30ILE C 23ALA C 124 | 1.48A | NoneNoneAPR C 201 (-3.9A)None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | TYR A 152VAL A 30ILE A 23ALA A 124 | 1.48A | NoneNoneAPR A 201 (-4.0A)None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | TYR D 152VAL D 30ILE D 23ALA D 124 | 1.51A | NoneNoneAPR D 201 (-3.8A)None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | TYR D 152VAL D 30ILE D 23ALA D 124 | 1.50A | NoneNoneAPR D 201 (-3.8A)None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wq3 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 4 / 7 | TYR A6845VAL B4295ILE A6838ALA A6843 | 1.43A | SAH A7101 (-4.5A)NoneNoneNone | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 7 | TYR A6845ILE A6925ILE A6967ALA A6966 | 1.72A | SAH A7101 (-4.5A)NoneNoneNone | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wq3 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 4 / 7 | TYR A6845VAL B4295ILE A6838ALA A6843 | 1.43A | SAH A7101 (-4.5A)NoneNoneNone | |||
![]() | 4LV9_B_20JB601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 7 | TYR A6950PHE A6954SER A6927SER A6896 | 1.78A | 21.04 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wqd | NSP8 (SARS-CoV-2) | 4 / 7 | VAL B 130ILE B 120ILE B 106ALA B 150 | 1.40A | NoneNoneNoneEDO B 302 (-3.7A) | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wqd | NSP8 (SARS-CoV-2) | 4 / 7 | VAL B 130ILE B 120ILE B 106ALA B 150 | 1.38A | NoneNoneNoneEDO B 302 (-3.7A) | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wqd | NSP8 (SARS-CoV-2) | 4 / 7 | VAL D 130ILE D 120ILE D 106ALA D 150 | 1.38A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wqd | NSP8 (SARS-CoV-2) | 4 / 7 | VAL D 130ILE D 120ILE D 106ALA D 150 | 1.41A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | TYR A 209ARG A 217ILE A 281ALA A 211 | 1.29A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.54A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.53A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 4 / 7 | TYR A 273HIS A 272ILE A 285ALA A 114 | 1.60A | GOL A 508 (-4.9A)PO4 A 502 (-3.7A)NoneNone | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 4 / 7 | TYR A 273HIS A 272ILE A 285ALA A 114 | 1.57A | GOL A 508 (-4.9A)PO4 A 502 (-3.7A)NoneNone | |||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | ARG A 4SER B 144ALA B 116SER B 123 | 1.40A | 21.05 | NoneO6K B 401 ( 3.9A)NoneGLY A 401 ( 4.7A) | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | TYR A 209ARG A 217ILE A 281ALA A 211 | 1.21A | 15.42 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | TYR A 209ARG A 217ILE A 281ALA A 211 | 1.24A | 15.42 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.54A | 15.42 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.54A | 15.42 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 7 | VAL D 130ILE D 120ILE D 106ALA D 150 | 1.42A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 7 | VAL D 130ILE D 120ILE D 106ALA D 150 | 1.45A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 7 | VAL B 130ILE B 120ILE B 106ALA B 150 | 1.38A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 7 | VAL B 130ILE B 120ILE B 106ALA B 150 | 1.42A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yi3 | NUCLEOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR A 72ILE A 90ARG A 48ILE A 91 | 1.71A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR E 508VAL E 510ILE E 410ILE E 418 | 1.39A | DMS E 902 (-4.0A)NoneNoneNone | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR A 508VAL A 510ILE A 410ILE A 418 | 1.38A | DMS A 903 (-3.5A)NoneNoneNone | |||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | PHE A 497ASP A 442SER A 438TYR A 451 | 1.68A | 17.80 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR E 508VAL E 510ILE E 410ILE E 418 | 1.39A | DMS E 902 (-4.0A)NoneNoneNone | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | VAL E 510ILE E 410ARG E 408ILE E 418 | 1.54A | NoneNoneMLI E 908 (-3.9A)None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | VAL A 510ILE A 410ARG A 408ILE A 418 | 1.55A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | VAL A 510ILE A 410ARG A 408ILE A 418 | 1.52A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | VAL E 510ILE E 410ARG E 408ILE E 418 | 1.51A | NoneNoneMLI E 908 (-3.9A)None | |||
![]() | 4LV9_B_20JB601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR A 451PHE A 497ASP A 442SER A 438 | 1.68A | 17.80 | None | ||
![]() | 4LV9_B_20JB601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR E 451PHE E 497ASP E 442SER E 438 | 1.72A | 17.80 | None | ||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | PHE E 497ASP E 442SER E 438TYR E 451 | 1.72A | 17.80 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR A 508VAL A 510ILE A 410ILE A 418 | 1.39A | DMS A 903 (-3.5A)NoneNoneNone | |||
![]() | 4LV9_B_20JB601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR E 451PHE E 347SER E 438ARG E 509 | 1.57A | 17.80 | None | ||
![]() | 4LV9_B_20JB601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR E 451PHE E 497ASP E 442SER E 438 | 1.78A | 17.80 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | VAL E 510ILE E 410ARG E 408ILE E 418 | 1.53A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR E 508VAL E 510ILE E 410ILE E 418 | 1.40A | None | |||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | PHE E 347ARG E 346ASP E 442SER E 438 | 1.58A | 17.80 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | VAL E 510ILE E 410ARG E 408ILE E 418 | 1.49A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | VAL E 350ILE E 402ILE E 410ALA E 419 | 1.70A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | VAL E 350ILE E 402ILE E 410ALA E 419 | 1.71A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR E 508VAL E 510ILE E 410ILE E 418 | 1.40A | None | |||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | PHE E 347SER E 438ARG E 509TYR E 451 | 1.59A | 17.80 | None | ||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | PHE E 497ASP E 442SER E 438TYR E 451 | 1.78A | 17.80 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.55A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.56A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR A 508VAL A 510ILE A 410ILE A 418 | 1.40A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR A 508VAL A 510ILE A 410ILE A 418 | 1.39A | None | |||
![]() | 4LV9_B_20JB601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR A 451PHE A 497ASP A 442SER A 438 | 1.72A | 18.24 | None | ||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | PHE E 497ASP E 442SER E 438TYR E 451 | 1.72A | 18.24 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | VAL A 510ILE A 410ARG A 408ILE A 418 | 1.51A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR E 508VAL E 510ILE E 410ILE E 418 | 1.38A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | VAL E 510ILE E 410ARG E 408ILE E 418 | 1.53A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR E 508VAL E 510ILE E 410ILE E 418 | 1.39A | None | |||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | PHE A 497ASP A 442SER A 438TYR A 451 | 1.73A | 18.24 | None | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | VAL E 510ILE E 410ARG E 408ILE E 418 | 1.50A | None | |||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | PHE E 347ARG E 346ASP E 442SER E 438 | 1.57A | 18.24 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | VAL A 510ILE A 410ARG A 408ILE A 418 | 1.54A | None | |||
![]() | 4LV9_B_20JB601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR E 451PHE E 497ASP E 442SER E 438 | 1.72A | 18.24 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.54A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | TYR A 209ARG A 217ILE A 281ALA A 211 | 1.32A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | TYR A 209ARG A 217ILE A 281ALA A 211 | 1.29A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.54A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR D 152VAL D 30ILE D 23ALA D 124 | 1.44A | NoneNoneEDO D 208 (-4.0A)None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | HIS D 94VAL D 35ILE D 23ALA D 50 | 1.71A | NoneNoneEDO D 208 (-4.0A)EDO D 206 (-3.6A) | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR C 152VAL C 30ILE C 23ALA C 124 | 1.54A | EDO C 203 (-4.8A)NoneNoneNone | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR D 152VAL D 30ILE D 23ALA D 124 | 1.45A | NoneNoneEDO D 208 (-4.0A)None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR E 152VAL E 30ILE E 23ALA E 124 | 1.43A | NoneNoneEDO E 205 (-4.2A)None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR A 152VAL A 30ILE A 23ALA A 124 | 1.45A | None | |||
![]() | 4LV9_B_20JB601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | PHE D 156ASP D 157SER C 84ALA C 60 | 1.52A | 17.50 | EDO D 209 ( 3.6A)NoneNoneNone | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR B 152VAL B 30ILE B 23ALA B 124 | 1.46A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR A 152VAL A 30ILE A 23ALA A 124 | 1.44A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR E 152VAL E 30ILE E 23ALA E 124 | 1.44A | NoneNoneEDO E 205 (-4.2A)None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR C 152VAL C 30ILE C 23ALA C 124 | 1.53A | EDO C 203 (-4.8A)NoneNoneNone | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR B 152VAL B 30ILE B 23ALA B 124 | 1.45A | None | |||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | PHE D 156ASP D 157SER C 84ALA C 60 | 1.52A | 17.50 | EDO D 209 ( 3.6A)NoneNoneNone | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR A 152VAL A 30ILE A 23ALA A 124 | 1.48A | NoneNoneAPR A 201 (-3.9A)None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR C 152VAL C 30ILE C 23ALA C 124 | 1.53A | NoneNoneAPR C 201 (-3.9A)None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR C 152VAL C 30ILE C 23ALA C 124 | 1.52A | NoneNoneAPR C 201 (-3.9A)None | |||
![]() | 4LV9_B_20JB601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | PHE D 156ASP D 157SER C 84ALA C 60 | 1.63A | 17.50 | EDO D 204 (-3.9A)NoneNoneEDO D 204 ( 4.8A) | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR B 152VAL B 30ILE B 23ALA B 124 | 1.45A | NoneNoneAPR B 201 (-4.1A)None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR E 152VAL E 30ILE E 23ALA E 124 | 1.43A | NoneNoneAPR E 201 (-4.1A)None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR A 152VAL A 30ILE A 23ALA A 124 | 1.47A | NoneNoneAPR A 201 (-3.9A)None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR B 152VAL B 30ILE B 23ALA B 124 | 1.44A | NoneNoneAPR B 201 (-4.1A)None | |||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | PHE D 156ASP D 157SER C 84ALA C 60 | 1.62A | 17.50 | EDO D 204 (-3.9A)NoneNoneEDO D 204 ( 4.8A) | ||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR E 152VAL E 30ILE E 23ALA E 124 | 1.45A | NoneNoneAPR E 201 (-4.1A)None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR D 152VAL D 30ILE D 23ALA D 124 | 1.50A | NoneNoneAPR D 201 (-3.9A)None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR D 152VAL D 30ILE D 23ALA D 124 | 1.51A | NoneNoneAPR D 201 (-3.9A)None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR A 152VAL A 30ILE A 23ALA A 124 | 1.47A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR A 152VAL A 30ILE A 23ALA A 124 | 1.46A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR B 152VAL B 30ILE B 23ALA B 124 | 1.45A | NoneNoneEDO B 202 (-4.0A)None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR B 152VAL B 30ILE B 23ALA B 124 | 1.47A | NoneNoneEDO B 202 (-4.0A)None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR C 152VAL C 30ILE C 23ALA C 124 | 1.51A | NoneNoneEDO C 206 (-4.1A)None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | TYR C 152VAL C 30ILE C 23ALA C 124 | 1.50A | NoneNoneEDO C 206 (-4.1A)None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.55A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.55A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7btf | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 728HIS A 725VAL A 42ILE A 715 | 1.43A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7btf | NSP8 (SARS-CoV-2) | 4 / 7 | VAL D 130ILE D 120ILE D 106ALA D 150 | 1.45A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7btf | NSP8 (SARS-CoV-2) | 4 / 7 | VAL D 130ILE D 120ILE D 106ALA D 150 | 1.47A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7btf | NSP12 (SARS-CoV-2) | 4 / 7 | VAL A 182ILE A 244ARG A 132ALA A 130 | 1.32A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7btf | NSP12NSP8 (SARS-CoV-2) | 4 / 7 | TYR A 273VAL A 330ILE B 120ILE B 106 | 1.55A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7btf | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 237VAL A 182ARG A 132ALA A 125 | 1.49A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7btf | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 479VAL A 693ILE A 579ILE A 589 | 1.68A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7btf | NSP12NSP8 (SARS-CoV-2) | 4 / 7 | TYR A 273VAL A 330ILE B 120ILE B 106 | 1.53A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7btf | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 237VAL A 182ARG A 132ALA A 125 | 1.52A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7btf | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 237VAL A 182ILE A 244ARG A 132 | 1.47A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7btf | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 479VAL A 693ILE A 579ILE A 589 | 1.68A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7btf | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 728HIS A 725VAL A 42ILE A 715 | 1.45A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7btf | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 237VAL A 182ILE A 244ARG A 132 | 1.48A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7btf | NSP12 (SARS-CoV-2) | 4 / 7 | VAL A 182ILE A 244ARG A 132ALA A 130 | 1.30A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.56A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 4 / 7 | TYR A 209VAL A 204ILE A 281ALA A 211 | 1.57A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 237VAL A 182ARG A 132ALA A 125 | 1.58A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 4 / 7 | TYR A 273VAL A 330ILE B 120ILE B 106 | 1.61A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 237VAL A 182ILE A 244ARG A 132 | 1.49A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 479VAL A 693ILE A 579ILE A 589 | 1.67A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 7 | VAL A 96ARG A 197ILE A 201ALA A 199 | 1.38A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 831VAL A 880ILE A 837ARG A 836 | 1.46A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 4 / 7 | TYR A 273VAL A 330ILE B 107ALA B 110 | 1.58A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 237VAL A 182ILE A 244ARG A 132 | 1.47A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 7 | VAL A 182ILE A 244ARG A 132ALA A 130 | 1.36A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 7 | VAL A 182ILE A 244ARG A 132ALA A 130 | 1.33A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 479VAL A 693ILE A 579ILE A 589 | 1.67A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 7 | VAL A 96ARG A 197ILE A 201ALA A 199 | 1.39A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 877VAL A 880ILE A 837ARG A 836 | 1.66A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 877VAL A 880ILE A 837ARG A 836 | 1.63A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 831VAL A 880ILE A 837ARG A 836 | 1.49A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 237VAL A 182ARG A 132ALA A 125 | 1.54A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 4 / 7 | TYR A 273VAL A 330ILE B 120ILE B 106 | 1.63A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 4 / 7 | TYR A 273VAL A 330ILE B 107ALA B 110 | 1.59A | None | |||
![]() | 4LV9_B_20JB601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 217ASP A 211ALA A 97ARG A 118 | 1.51A | 20.68 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 4 / 7 | TYR A 273VAL A 330ILE B 120ILE B 106 | 1.67A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 479VAL A 693ILE A 579ILE A 589 | 1.67A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 7 | VAL A 182ILE A 244ARG A 132ALA A 130 | 1.25A | None | |||
![]() | 4LV9_A_20JA601_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 8 | ASP A 211ALA A 97ARG A 118TYR A 217 | 1.52A | 20.68 | None | ||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 4 / 7 | TYR A 273VAL A 330ILE B 107ALA B 110 | 1.50A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 4 / 7 | TYR A 273VAL A 330ILE B 107ALA B 110 | 1.50A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 237VAL A 182ARG A 132ALA A 125 | 1.39A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 728HIS A 725VAL A 42ILE A 715 | 1.35A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 479VAL A 693ILE A 579ILE A 589 | 1.68A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 728HIS A 725VAL A 42ILE A 715 | 1.33A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 4 / 7 | TYR A 273VAL A 330ILE B 120ILE B 106 | 1.65A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 237VAL A 182ILE A 244ARG A 132 | 1.57A | None | |||
![]() | 4LV9_B_20JB602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 237VAL A 182ARG A 132ALA A 125 | 1.42A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 7 | VAL A 182ILE A 244ARG A 132ALA A 130 | 1.23A | None | |||
![]() | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 7 | TYR A 237VAL A 182ILE A 244ARG A 132 | 1.56A | None |